SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

267.3488556

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

30.42

15438.07

EPS(TTM)

Face Value()

Div & Yield %

25.82

1.4

Back

Mahindra Lifespace Developers reports consolidated net profit of Rs 108.88 crore in the December 2025 quarter

Feb 02,2026

Net profit of Mahindra Lifespace Developers reported to Rs 108.88 crore in the quarter ended December 2025 as against net loss of Rs 22.49 crore during the previous quarter ended December 2024. Sales rose 174.49% to Rs 459.16 crore in the quarter ended December 2025 as against Rs 167.28 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	459.16	167.28	174
OPM %	6.49	-15.18	-
PBDT	109.28	-1.18	LP
PBT	103.61	-5.15	LP
NP	108.88	-22.49	LP

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)